Evidence map›Paper›PMID 29581256›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors.

Dongshi Chen, Jingshan Tong, Liheng Yang, Liang Wei, Donna B Stolz, Jian Yu, Jianke Zhang, Lin Zhang

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 177 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. The Multifaceted Roles of Neutrophil Death in COPD and Lung Cancer.Journal of respiratory biology and translational medicine · 2025
    Article
  20. Review

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dongshi ChenUPMC Hillman Cancer Center, Pittsburgh, PA 15213.ORCID 0000-0002-8973-5606
Jingshan TongUPMC Hillman Cancer Center, Pittsburgh, PA 15213.
Liheng YangUPMC Hillman Cancer Center, Pittsburgh, PA 15213.
Liang WeiUPMC Hillman Cancer Center, Pittsburgh, PA 15213.
Donna B StolzUPMC Hillman Cancer Center, Pittsburgh, PA 15213.
Jian YuUPMC Hillman Cancer Center, Pittsburgh, PA 15213.
Jianke ZhangDepartment of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107.
Lin ZhangUPMC Hillman Cancer Center, Pittsburgh, PA 15213; zhanglx@upmc.edu.
University of Pittsburgh · USThomas Jefferson University · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Training and EducationU19AI068021 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENBERGER, JOEL S · 2005 to 2019
$44.4M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancerR01CA217141 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NIKOLOVSKA-COLESKA, ZANETA, ZHANG, LIN · 2017 to 2021
$2.6M
Translation addiction and targeting in colon cancerR01CA215481 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YU, JIAN · 2018 to 2022
$2.3M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21U01DK085570 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YU, JIAN · 2009 to 2014
$2.2M
Role of Mcl-1 degradation in colorecal cancer therapyR01CA203028 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHANG, LIN · 2016 to 2020
$1.7M
Bid-mediated killing of oncogenic stem cells in chemopreventionR01CA172136 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHANG, LIN · 2013 to 2017
$1.6M
NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA172136NCI NIH HHS R01 CA203028NCI NIH HHS R01 CA215481NCI NIH HHS R01 CA217141NIAID NIH HHS U19 AI068021NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U01 DK085570NIDDK NIH HHS U24 DK085532
6 · The paper itself

Abstract

Necroptosis, a form of regulated necrotic cell death, is governed by RIP1/RIP3-mediated activation of MLKL. However, the signaling process leading to necroptotic death remains to be elucidated. In this study, we found that

Indexed as

ApoptosisAnimalsApoptosis Regulatory ProteinsCell Line, TumorCytosolDNADNA-Binding ProteinsGlycoproteinsHumansMembrane ProteinsMiceMitochondriaNecrosisNF-kappa BPhosphorylationProtein KinasesApoptosis Regulatory ProteinsBBC3 protein, humanDNADNA-Binding ProteinsGlycoproteinsMembrane ProteinsMLKL protein, mouseNF-kappa BProtein KinasesProto-Oncogene ProteinsPUMA protein, mouseReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanRipk3 protein, mouseRNA-Binding ProteinsSTING1 protein, humanSting1 protein, mouseSTING ProteinTumor Necrosis Factor-alphaTumor Suppressor ProteinsZBP1 protein, humanZbp1 protein, mouseMLKLnecroptosisNF-κBPUMARIP3

Identifiers

PMID29581256
PMCPMC5899441
OpenAlexW2791998267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.